Pulmonary fibrosis
MONDO:0002771Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).
Also known as: pulmonary interstitial fibrosis
181 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Hormone drug may slow Aging-Related diseases in rare condition
Disease control CompletedThis study tested whether low doses of the hormone drug danazol can slow the shortening of telomeres—the protective caps on DNA—in people with telomere diseases. These conditions can cause bone marrow failure, lung scarring, and liver damage. Eighteen participants took danazol fo…
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a lung drug stop COVID scarring?
Disease control CompletedThis study tested whether nintedanib, a drug used for other lung diseases, can slow down lung damage in people who had severe COVID-19. It included 103 adults who still had lung problems more than 30 days after their COVID diagnosis. The main goal was to see if the drug helped ma…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Umbilical cord stem cells tested for rare lung condition
Disease control CompletedThis study tested a single intravenous infusion of stem cells from donated umbilical cord tissue in one person with severe scleroderma that had caused lung scarring and high blood pressure in the lungs. The goal was to see if the treatment could improve lung function, exercise ab…
Phase: PHASE1, PHASE2 • Sponsor: Fundación Neumologica Colombiana • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a common supplement slow lung scarring? new trial targets gene clue
Disease control CompletedThis study tested whether the antioxidant N-acetylcysteine (NAC) can slow lung decline in people with idiopathic pulmonary fibrosis (IPF) who have a specific gene variant (TOLLIP TT). Over 200 participants took NAC or a placebo for 24 months. The goal was to see if NAC delays wor…
Phase: PHASE3 • Sponsor: Fernando J Martinez • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New hope for kids with rare lung disease: long-term drug safety trial completed
Disease control CompletedThis study looked at the long-term safety of a medicine called nintedanib in children and teenagers with a rare lung condition that causes scarring (fibrosing interstitial lung disease). All 54 participants took nintedanib capsules twice a day for at least 1.5 to 3 years. The goa…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug BMS-986278 tested in 403 lung fibrosis patients
Disease control CompletedThis Phase 2 trial tested an experimental drug called BMS-986278 in 403 adults with pulmonary fibrosis, a condition that causes lung scarring and breathing difficulty. The study compared the drug to a placebo to see if it could improve lung function and was safe. Results will hel…
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy aims to improve lung function in stubborn lung disease
Disease control CompletedThis study tested whether adding rituximab (a drug that calms certain immune cells) to standard mycophenolate mofetil treatment helps people with interstitial lung disease whose lungs are not responding to initial therapy. 122 adults with various ILD types received either rituxim…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThis study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. The main goal was to see if the drug is safe and tolerable over 12 weeks compared to a placebo. Resea…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a cancer drug ease arthritis in scleroderma patients?
Disease control CompletedThis study tested whether rituximab, a drug used for certain cancers and autoimmune diseases, can reduce joint pain and swelling in people with systemic sclerosis (scleroderma). Twenty-two adults with active arthritis took rituximab or a placebo, plus standard care. Researchers c…
Phase: PHASE2, PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for rare lung scarring? small trial tests pirfenidone
Disease control CompletedThis small pilot study looked at whether the drug pirfenidone is safe and effective for people with a specific type of lung scarring (pulmonary fibrosis) linked to MPO antibodies or vasculitis. Seven adults took the drug for a year, and researchers measured changes in lung functi…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a chemo combo save lungs in scleroderma patients?
Disease control CompletedThis study tested whether a combination of the chemotherapy drug cyclophosphamide and the steroid prednisone could help people with scleroderma-related lung disease. Forty adults whose lung function had worsened in the past year received either the drug combo or a placebo plus pr…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
Could a simple breath test spot hidden diseases early?
Diagnosis CompletedThis study is testing a portable, non-invasive breath analyzer that measures tiny particles in exhaled breath to screen for conditions like type 2 diabetes, liver disease, kidney disease, and lung disease. Researchers will enroll healthy volunteers and people with known diagnoses…
Sponsor: Respyr • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Which lung biopsy is safest and most accurate? new study has answers
Diagnosis CompletedThis study looked at three ways to take a small sample of lung tissue (biopsy) in 60 adults with interstitial lung diseases. The goal was to find which method gives the most accurate diagnosis and causes the fewest side effects. The methods tested were forceps biopsy, cryobiopsy …
Phase: NA • Sponsor: Mansoura University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Radiation-Free lung scans for kids? new MRI shows promise
Diagnosis CompletedThis study tested a new MRI technique that can take pictures of children's lungs without using radiation or injecting contrast dye. 72 children aged 6-16 had both a standard CT scan and this new MRI. The goal was to see if the MRI could produce clear images of the lungs, potentia…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 26, 2026 15:40 UTC
-
Can oxygen during exercise supercharge lung rehab for ILD patients?
Symptom relief CompletedThis trial investigates whether adding high-flow nasal oxygen during exercise training can improve endurance and quality of life for people with chronic fibrotic interstitial lung disease (ILD). Participants undergo a 4-week pulmonary rehabilitation program, receiving either high…
Phase: NA • Sponsor: Frédéric Hérengt • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Small study tackles nasty side effect of lung drug
Symptom relief CompletedThis study followed 18 people in Spain with idiopathic pulmonary fibrosis (IPF) or other progressive lung scarring who were taking nintedanib (OFEV) and had developed diarrhea. The goal was to see if the diarrhea could be controlled after 12 weeks while staying on the full dose. …
Sponsor: Boehringer Ingelheim • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New hope for preventing Post-Surgery confusion in seniors
Symptom relief CompletedThis study tested whether giving a small amount of s-ketamine during chest surgery could reduce the risk of postoperative delirium (sudden confusion) in patients aged 60 and older. Over 500 participants were randomly assigned to receive either s-ketamine or another drug (dexmedet…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Ice your pain away: nerve freezing may cut opioid use after lung surgery
Symptom relief CompletedThis study tested freezing the nerves between the ribs during robot-assisted lung surgery to see if it reduces pain and the need for painkillers afterward. 33 adults having lung surgery were randomly assigned to get the nerve freeze or standard pain medicine. Researchers tracked …
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a tiny dose of muscle relaxant make lung scopes safer?
Symptom relief CompletedThis study looked at whether giving a low dose of a muscle relaxant (rocuronium) during bronchoscopy—a procedure where a tube is inserted into the lungs—could reduce complications like throat spasms and coughing. 153 adults having elective bronchoscopy were split into two groups:…
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Smart oxygen machine may ease walking for lung disease patients
Symptom relief CompletedThis study tested a new automatic oxygen device in 29 people with fibrotic lung disease (scarred lungs). The device automatically adjusts oxygen flow during walking to keep oxygen levels steady. The goal was to see if it reduces breathlessness compared to the usual fixed oxygen d…
Phase: NA • Sponsor: Janne Hastrup Jensen • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Lung disease mystery: 1500 patients to be tracked for clues
Knowledge-focused CompletedThis study follows 1500 adults with interstitial lung disease to understand how the condition changes over time. Researchers will track symptoms, lung function, and treatments used. The goal is to build a detailed picture of the disease's course and improve future care.
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists examine lung cells to understand chronic lung disease
Knowledge-focused CompletedThis study looked at immune cells called alveolar macrophages in the lungs of 18 people with non-infectious lung diseases. Researchers used a technique called flow cytometry to study the surface proteins on these cells. The goal was to better understand the role of these cells in…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New MRI scan could replace painful kidney biopsies for transplant patients
Knowledge-focused CompletedThis study tested a special MRI technique called magnetic resonance elastography (MRE) to see if it can detect scarring in transplanted kidneys. Researchers compared MRE results with traditional biopsy samples from 73 kidney transplant patients. The goal was to find a non-invasiv…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New approach to CPR talks may help patients and families feel heard
Knowledge-focused CompletedThis study tested a new way for doctors to discuss CPR with older, seriously ill patients and their families. Instead of the usual conversation, doctors followed a step-by-step guide that focused on the patient's values and explained why CPR might not help. The goal was to see if…
Phase: PHASE2, PHASE3 • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New screening method could catch hidden lung complication early
Knowledge-focused CompletedThis study looked at ways to screen for pulmonary hypertension (high blood pressure in the lungs) in people who already have interstitial lung disease. The goal was to find this complication earlier. 314 adults with various types of lung disease took part in the screening tests.
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Pigeon Lovers' lung disease: genes may hold the key
Knowledge-focused CompletedThis study looked at whether certain genes make people who are regularly around pigeons more likely to develop a type of lung disease called hypersensitivity pneumonitis. Researchers analyzed the DNA of 475 pigeon fanciers to find genetic markers linked to lung scarring. The goal…
Sponsor: University of Dundee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Ultrasound vs. blood test: which better measures lung severity?
Knowledge-focused CompletedThis study looked at 86 ICU patients with a lung condition called interstitial syndrome. Researchers compared a lung ultrasound score with a standard blood oxygen test to see if the ultrasound could reliably measure how severe the condition was. They repeated both tests at the st…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Could a stroll beat a sprint for oxygen testing?
Knowledge-focused CompletedThis study looked at 93 people with lung disease who get short of breath when active. Participants did two 6-minute walk tests: one at their fastest pace and one at their normal walking speed. The goal was to see if the normal-speed test gives a more accurate picture of when they…
Phase: NA • Sponsor: Hampshire Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New study tracks breathing difficulties in lung scarring patients
Knowledge-focused CompletedThis study followed 51 people with idiopathic pulmonary fibrosis (IPF) for 6 months to understand how their shortness of breath changes over time. Researchers measured both the physical sensation and the emotional impact of breathlessness, and looked at how these relate to lung f…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Can MRI replace CT scans for lung fibrosis in scleroderma?
Knowledge-focused CompletedThis study tested whether a special MRI technique can measure lung stiffness in people with scleroderma, a disease that often causes lung scarring. Researchers enrolled 24 adults and compared MRI results to standard lung function tests. The goal was to see if MRI could offer a sa…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Oximeter showdown: which device gives the best oxygen reading?
Knowledge-focused CompletedThis study tested three different oximeters (Masimo, Nellcor, Nonin) at various oxygen targets in 40 patients with and without COPD. The goal was to see how the choice of oximeter and target affects the amount of oxygen needed. Results could help guide safer oxygen therapy.
Phase: NA • Sponsor: Laval University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New inhaled drug tested in healthy volunteers for lung scarring disease
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles an inhaled drug called CHF10073 in 155 healthy volunteers. The drug is being developed for pulmonary fibrosis, a serious lung-scarring condition. The trial looked at different single and multiple doses, and also ch…
Phase: PHASE1 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New MRI technique could better track lung treatment success
Knowledge-focused CompletedThis study tested a special MRI technique using a harmless gas to see how well it can show changes in the lungs of people with interstitial lung disease. Researchers worked with 46 volunteers to find the best way to use this scan. The goal is to create a standard method that doct…
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Drug combo safety check: early study completed
Knowledge-focused CompletedThis completed Phase 1 trial studied how deupirfenidone (LYT-100) and nintedanib interact in 24 healthy adults aged 18-65. Participants took both drugs over several weeks to measure drug levels and check for side effects. The goal was to understand potential drug-drug interaction…
Phase: PHASE1 • Sponsor: PureTech • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
New MRI technique aims to sharpen lung images
Knowledge-focused CompletedThis study tested a special MRI technique called Ultra Short Echo Time (UTE) to see if it can take clearer pictures of the lungs than traditional MRI. Researchers collected images and health information from people with and without lung disease to help doctors better understand l…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt for genetic clues in rare lung syndrome
Knowledge-focused CompletedThis study looked at 250 people to understand why some smokers develop a rare lung condition called combined pulmonary fibrosis and emphysema (CPFE). Researchers compared telomere length and genetic mutations in patients with CPFE, those with only fibrosis or emphysema, and healt…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Hospital dietitians boost nutrition in lung patients, study finds
Knowledge-focused CompletedThis study tested whether having a dietitian help patients with lung disease order meals during a hospital stay could improve their nutrition and reduce the chance of being readmitted after discharge. 41 patients at nutritional risk took part. Researchers measured daily food inta…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
First human tests begin for potential lung and tumor drug
Knowledge-focused CompletedThis study tested a new drug called 9MW3811 for the first time in humans. The main goal was to check if it is safe and how well it is tolerated in 32 healthy adults aged 18 to 55. Researchers gave a single dose and monitored for side effects, measuring how the drug moves through …
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
AI boosts chest X-Ray reading in UK hospital study
Knowledge-focused CompletedThis study tested whether an AI tool called Lunit INSIGHT CXR helps healthcare professionals read chest X-rays more accurately and quickly. Thirty doctors and radiographers reviewed 500 past chest X-rays from two UK hospitals, once with and once without AI help. The goal was to s…
Sponsor: Oxford University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
H1N1 survivors' lungs still show damage years later, study finds
Knowledge-focused CompletedThis study followed 38 adults who survived severe breathing failure from the 2009 H1N1 flu. Researchers compared those who needed a machine to oxygenate their blood (ECMO) with those who did not. They measured lung function, quality of life, and mental health at least 9 months af…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Doctors test which score best predicts lung disease survival
Knowledge-focused CompletedThis completed study looked at 143 people with two types of lung scarring diseases (IPF and hypersensitivity pneumonitis). Researchers compared three different scoring systems (GAP, ILD-GAP, and CPI) to see which one best predicts how long patients might live. The goal was to fin…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:07 UTC